Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680784 · ClinicalTrials.gov registry record · Phase 3
HKT-500 in Adult Patients With Ankle Sprain
A Phase 3 study, sponsored by Hisamitsu Pharmaceutical Co..
- Completed
- Registry status
- Phase 3
- Development phase
- 260
- Enrollment target
NCT00680784 is a Phase 3 study that has completed, run by Hisamitsu Pharmaceutical Co.. The registered enrollment target is 260 participants.
The verdict
NCT00680784, a Phase 3 study, has completed, sponsored by Hisamitsu Pharmaceutical Co..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 260 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.
Interventions
- OTHER Placebo Patch
- DRUG HKT-500 Ketoprofen Topical Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2008-04 |
| Est. Completion | 2008-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680784
The ClinicalTrials.gov registry entry for NCT00680784 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hisamitsu Pharmaceutical Co., which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Patch is the first listed.
NCT00680784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680784 about?
NCT00680784 is a clinical study titled "HKT-500 in Adult Patients With Ankle Sprain". The objective of this study is to demonstrate the multiple-dose efficacy and safety of HKT-500 for the treatment of ankle sprain.
What is the current status of trial NCT00680784?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 260 participants. The study started on 2008-04. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00680784?
The interventions under investigation include: Placebo Patch (OTHER), HKT-500 Ketoprofen Topical Patch (DRUG).
Who is sponsoring clinical trial NCT00680784?
This trial is sponsored by Hisamitsu Pharmaceutical Co., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.